High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors.
暂无分享,去创建一个
C. Bokemeyer | O. Rick | A. Neubauer | A. Lorch | J. Hartmann | M. Hackenthal | J. Beyer | A. Dieing
[1] C. Bokemeyer,et al. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] S. Perkins,et al. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. , 2007, The New England journal of medicine.
[3] C. Bokemeyer,et al. Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] M. Bains,et al. Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] J. Bacik,et al. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] R. Huddart,et al. A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial , 2005, British Journal of Cancer.
[7] W. Siegert,et al. A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] J. Bacik,et al. Salvage chemotherapy for patients with advanced pure seminoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] W. Siegert,et al. Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] K. Cornetta,et al. High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] D. Huhn,et al. High-dose chemotherapy in germ cell tumours: a large single centre experience. , 1998, European journal of cancer.
[12] Richard Sylvester,et al. International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers , 1997 .
[13] D. Huhn,et al. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.